Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.65 Insider Own0.20% Shs Outstand145.01M Perf Week4.89%
Market Cap529.29M Forward P/E- EPS next Y-0.53 Insider Trans0.00% Shs Float143.18M Perf Month13.00%
Income-92.80M PEG- EPS next Q-0.16 Inst Own90.40% Short Float10.03% Perf Quarter5.80%
Sales137.90M P/S3.84 EPS this Y-4.60% Inst Trans-4.19% Short Ratio7.17 Perf Half Y28.52%
Book/sh-0.26 P/B- EPS next Y22.10% ROA-49.40% Target Price8.00 Perf Year-28.29%
Cash/sh0.76 P/C4.82 EPS next 5Y10.00% ROE- 52W Range2.38 - 5.57 Perf YTD-13.51%
Dividend- P/FCF- EPS past 5Y8.60% ROI-108.50% 52W High-34.47% Beta2.20
Dividend %- Quick Ratio3.00 Sales past 5Y13.90% Gross Margin83.20% 52W Low53.36% ATR0.18
Employees177 Current Ratio3.00 Sales Q/Q251.20% Oper. Margin-59.70% RSI (14)52.38 Volatility4.81% 5.18%
OptionableYes Debt/Eq- EPS Q/Q-93.60% Profit Margin-67.30% Rel Volume0.67 Prev Close3.69
ShortableYes LT Debt/Eq- EarningsNov 03 BMO Payout- Avg Volume2.00M Price3.65
Recom1.50 SMA203.66% SMA500.34% SMA2008.39% Volume1,340,239 Change-1.08%
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
Sep-21-16 01:38PM  5 Stocks Insiders Love Right Now
11:23AM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : September 21, 2016
Sep-20-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016
Sep-18-16 10:15AM  10 Analyst Stock Picks Under $10 for Massive Upside at 24/7 Wall St.
Sep-14-16 08:25PM  Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY) at Investopedia
12:08PM  Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today at Insider Monkey
08:20AM  Key FDA Decisions and Trial Results Coming in the Next 2 Months at 24/7 Wall St.
07:33AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA PR Newswire
Sep-12-16 01:55PM  Why Array Biopharma May Become a Winner (ARRY) at Investopedia +5.56%
Sep-11-16 04:00PM  How To Approach Momentum Trading Like A Pro at Investopedia
Sep-09-16 08:12AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 9, 2016 -6.81%
Sep-06-16 11:00AM  Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference PR Newswire
Sep-04-16 10:40AM  5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside at 24/7 Wall St.
Sep-02-16 04:19PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
02:33PM  What Are Array Biopharma Inc (ARRY)s Chances Of PDUFA Success? at Insider Monkey
09:29AM  Array (ARRY) Oncology Drug Accepted for Review in the U.S.
07:40AM  8 Major FDA Decisions and Trial Results to Watch for in September at 24/7 Wall St.
Sep-01-16 08:04AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma PR Newswire
Aug-31-16 11:28AM  Array (ARRY) Presents Positive Cardiovascular Trial Data
09:00AM  Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference PR Newswire
Aug-30-16 12:20PM  Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win at 24/7 Wall St.
08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress PR Newswire
Aug-29-16 03:51PM  Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies +6.17%
08:55AM  Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More at 24/7 Wall St.
Aug-25-16 01:04PM  ARRAY BIOPHARMA INC Financials
Aug-23-16 11:20AM  ETFs with exposure to Array BioPharma, Inc. : August 23, 2016
Aug-22-16 09:40AM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016 +6.48%
Aug-19-16 03:26PM  Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress PR Newswire -6.90%
08:32AM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report
Aug-14-16 10:05AM  Top 6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-11-16 12:31PM  ETFs with exposure to Array BioPharma, Inc. : August 11, 2016
Aug-10-16 12:54PM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016
10:55AM  Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08:14AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016
Aug-09-16 03:37PM  Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial -22.70%
11:05AM  3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential at 24/7 Wall St.
07:40AM  Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals at MarketWatch
06:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:01AM  AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer PR Newswire
Aug-05-16 03:00PM  Edited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT
08:25AM  Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher
Aug-04-16 09:11AM  Array BioPharma reports 4Q loss +9.27%
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:00AM  Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 PR Newswire
07:07AM  Q4 2016 Array Biopharma Inc Earnings Release - Before Market Open
Aug-03-16 05:05PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jul-28-16 08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:00AM  Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer PR Newswire
Jul-27-16 04:56PM  Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 On August 4, 2016 PR Newswire
Jul-18-16 09:32AM  Biotech Equities Technical Briefing on Array BioPharma, Geron, Emergent BioSolutions, and Global Blood Therapeutics
Jul-07-16 06:36PM  Array BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference PR Newswire
Jul-01-16 12:33PM  Why These Stocks Are Trending on Friday at Insider Monkey
08:37AM  Why Array Is Making a Run at 24/7 Wall St.
Jun-30-16 04:03PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:00PM  Array BioPharma Submits Binimetinib New Drug Application to U.S. FDA PR Newswire
Jun-28-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : June 28, 2016
Jun-17-16 11:52AM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : June 17, 2016
Jun-16-16 08:18AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : June 16, 2016
Jun-09-16 10:27AM  Here's Why Array Biopharma Inc. Gained 18.1% in May at Motley Fool
Jun-08-16 10:10AM  All You Need To Know About Array Biopharma Inc (ARRY)s Upcoming NDA Submission at Insider Monkey
Jun-06-16 02:20PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:15PM  Array Presents Full Results from Phase 3 NEMO Study PR Newswire
Jun-04-16 09:00AM  Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks PR Newswire
09:00AM  Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial PR Newswire
Jun-03-16 09:30AM  Redmile Group Sticking With Healthcare Picks After Rough Q1 at Insider Monkey
Jun-02-16 02:20PM  Array BioPharma To Present At The Jefferies 2016 Global Healthcare Conference PR Newswire
May-31-16 12:31PM  Most Popular Healthcare Stocks Under $5 at Insider Monkey
May-26-16 07:10PM  ETFs with exposure to Array BioPharma, Inc. : May 26, 2016
May-23-16 08:15AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : May 23, 2016
May-18-16 05:26PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:05PM  Array BioPharma Announces Key Data from NRAS-mutant Melanoma and BRAF-mutant Colorectal Cancer ASCO 2016 Presentations PR Newswire
May-09-16 08:30AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : May 9, 2016
May-05-16 07:00PM  Array BioPharma To Present At The Bank of America Merrill Lynch HealthCare Conference PR Newswire
May-04-16 05:44PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
01:12AM  Edited Transcript of ARRY earnings conference call or presentation 4-May-15 1:00pm GMT
May-03-16 09:03PM  Edited Transcript of ARRY earnings conference call or presentation 3-May-16 1:00pm GMT
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:46AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:16AM  Array BioPharma reports 3Q loss AP
08:00AM  Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016 PR Newswire
07:07AM  Q3 2016 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Apr-26-16 12:25PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016 PR Newswire
Apr-25-16 09:36AM  Why Patents are the Lifeblood of Biotech Companies Accesswire
Apr-17-16 05:17PM  Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study at TheStreet
Apr-01-16 09:41AM  Array Bio ends late-stage study of ovarian cancer drug Reuters
09:16AM  Array Bio stops study testing drug for ovarian cancer Reuters
09:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer PR Newswire
Mar-31-16 09:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization Collaboration For Novel Pain And Inflammation Program PR Newswire
Mar-24-16 03:51PM  Five Cheap Healthcare Stocks With Hedge Fund Support at Insider Monkey +5.15%
Mar-23-16 08:28AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : March 23, 2016 -7.48%
Mar-09-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 9, 2016
Mar-08-16 08:47AM  Array Biopharma draws upside position -6.33%
Mar-01-16 12:53PM  Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference PR Newswire +6.77%
Feb-29-16 05:05AM  Edited Transcript of ARRY earnings conference call or presentation 3-Feb-15 2:00pm GMT
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II clinical trials comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASLAN001/Varlitinib, a pan-HER2 inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; Prexasertib/LY2606368, a chk-1 inhibitor for cancer; LOXO-101, a PanTrk inhibitor for cancer; and ONT-380/ARRY-380, an HER2 inhibitor for breast cancer. The company's Phase I drugs include GDC-0994, an ERK inhibitor for cancer; and ARRY-382, a CSF1R inhibitor for cancer, as well as Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandor VictorChief Medical OfficerSep 22Option Exercise3.6995,890353,834200,733Sep 23 07:52 PM
Redmile Group, LLC10% OwnerSep 15Buy3.5028,00098,00019,150,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 15Sale3.547,30025,84219,122,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Buy3.51372,0001,305,72019,129,950Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Sale3.50392,7001,374,45018,757,950Sep 16 04:00 PM
Redmile Group, LLC10% OwnerJan 12Buy3.6075,000270,00018,850,650Jan 14 04:14 PM
Redmile Group, LLC10% OwnerJan 11Buy3.54275,000973,50018,775,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 08Buy3.72350,0001,302,00018,500,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 07Buy3.73300,0001,119,00018,150,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerOct 01Buy4.50100,140450,63018,033,102Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 30Buy4.67182,452852,05117,932,962Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 29Buy4.56500,0002,280,00017,750,510Oct 01 07:15 PM